Glenmark Archives

Celebrating 20 Years of IP Excellence

Exacting Standards for Pharma Trademarks and their Dominant Parts

In this infringement and passing off case filed by Sun Pharma against Glenmark, the Court was asked to determine if the trademark “INDAMET” infringes upon the trademark “ISTAMET XR CP”. Sun Pharma’s “ISTAMET XR CP” was registered in 2014 by its predecessor in title, and Glenmark’s trademark, INDAMET, was registered in 2021. Continue Reading Exacting Standards for Pharma Trademarks and their Dominant Parts

April 25, 2024 BananaIP Reporter Case Reviews, Intellectual Property, Trademarks 0Comment 649Views 1Like

ShareFacebook

Merck v. Glenmark – A Bitter Battle of Pills

The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin) and “Janumet” (combination of sitagliptin and metformin) in its latest order dated October 7, 2015. The order restrains Glenmark from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs or from…

October 9, 2015 BananaIP Reporter Intellectual Property 0Comment 4419Views 0Like

ShareFacebook

Celebrating 20 Years of IP Excellence

Exacting Standards for Pharma Trademarks and their Dominant Parts

Merck v. Glenmark – A Bitter Battle of Pills

Connect with Us

BananaIP has been acknowledged as a women-owned enterprise, certified by WEConnect International.

Connect with us